Correlation Between Actinogen Medical and Bio Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Actinogen Medical and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinogen Medical and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Actinogen Medical and Bio Gene Technology, you can compare the effects of market volatilities on Actinogen Medical and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinogen Medical with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinogen Medical and Bio Gene.

Diversification Opportunities for Actinogen Medical and Bio Gene

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Actinogen and Bio is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Actinogen Medical and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Actinogen Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinogen Medical are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Actinogen Medical i.e., Actinogen Medical and Bio Gene go up and down completely randomly.

Pair Corralation between Actinogen Medical and Bio Gene

Assuming the 90 days trading horizon Actinogen Medical is expected to generate 6.78 times less return on investment than Bio Gene. But when comparing it to its historical volatility, Actinogen Medical is 5.11 times less risky than Bio Gene. It trades about 0.07 of its potential returns per unit of risk. Bio Gene Technology is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  4.30  in Bio Gene Technology on November 3, 2024 and sell it today you would earn a total of  0.60  from holding Bio Gene Technology or generate 13.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Actinogen Medical  vs.  Bio Gene Technology

 Performance 
       Timeline  
Actinogen Medical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Actinogen Medical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Actinogen Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bio Gene Technology 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Gene Technology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Bio Gene may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Actinogen Medical and Bio Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Actinogen Medical and Bio Gene

The main advantage of trading using opposite Actinogen Medical and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinogen Medical position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.
The idea behind Actinogen Medical and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules